Outcomes of Intravenous Recombinant Tissue Plasminogen Activator Therapy According to Gender: A Clinical Registry Study and Systematic Review

Background and Purpose— The natural history of stroke is worse in women than in men. Controversial data have been published on the efficacy of thrombolysis with recombinant tissue plasminogen activator (rtPA) according to gender. We evaluated gender differences in the efficacy and safety outcomes of intravenous rtPA using a clinical registry and systematic review. Methods— Since January 2002, we collected baseline characteristics and efficacy and safety outcomes for patients who received intravenous rtPA in our center. We performed a systematic PubMed literature search for previous observational studies that examined gender effects on outcomes after intravenous rtPA treatment. Results— No gender difference in good outcome at 3 months (adjusted OR for women, 1.41; 95% CI, 0.76 to 2.60) and in 90-day mortality (adjusted OR, 1.38; 95% CI, 0.59 to 3.19) was found in our registry. We identified 16 studies that evaluated the gender effect among intravenous rtPA-treated patients. None of these studies supported a gender difference in favorable outcome, and one suggested an increased risk of mortality in men. In unadjusted partial meta-analysis in 4074 women and 5840 men including our registry data, we found a trend toward a lower risk of symptomatic intracranial hemorrhage in women (crude OR, 0.87; 95% CI, 0.68 to 1.10). Conclusions— These results suggest no gender difference in outcome among patients treated with intravenous rtPA.

[1]  Gary A. Ford,et al.  Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.

[2]  D. Kent,et al.  The gender effect in stroke thrombolysis , 2008, Neurology.

[3]  J. De Keyser,et al.  Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. , 2008, Archives of neurology.

[4]  Á. Chamorro,et al.  The response to IV rt‐PA in very old stroke patients , 2008, European journal of neurology.

[5]  Determinants of outcome in patients eligible for thrombolysis for ischemic stroke , 2007, Vascular health and risk management.

[6]  W. Heiss,et al.  The Cologne Stroke Experience: Safety and Outcome in 450 Patients Treated with Intravenous Thrombolysis , 2007, Cerebrovascular Diseases.

[7]  G. Albers,et al.  Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors , 2007, Cerebrovascular Diseases.

[8]  W. Koroshetz,et al.  Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke , 2007, Neurology.

[9]  Zsolt Garami,et al.  Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke , 2007, Stroke.

[10]  A. Alexandrov,et al.  Clinical Deterioration After Intravenous Recombinant Tissue Plasminogen Activator Treatment: A Multicenter Transcranial Doppler Study , 2007, Stroke.

[11]  M. A. Moro,et al.  Increased Body Iron Stores Are Associated With Poor Outcome After Thrombolytic Treatment in Acute Stroke , 2007, Stroke.

[12]  J. Martí-Fàbregas,et al.  Frequency and Predictors of Symptomatic Intracerebral Hemorrhage in Patients with Ischemic Stroke Treated with Recombinant Tissue Plasminogen Activator outside Clinical Trials , 2006, Cerebrovascular Diseases.

[13]  D. Kent,et al.  Sex-Based Differences in the Effect of Intra-Arterial Treatment of Stroke: Analysis of the PROACT-2 Study , 2006, Stroke.

[14]  V. Hachinski,et al.  Neglecting the Difference: Does Right or Left Matter in Stroke Outcome After Thrombolysis? , 2006, Stroke.

[15]  C. Baumann,et al.  Early Recurrent Ischemic Stroke in Stroke Patients Undergoing Intravenous Thrombolysis , 2006, Circulation.

[16]  M. Schrooten,et al.  Body temperature and outcome after stroke thrombolysis , 2006, Acta neurologica Scandinavica.

[17]  J. Montaner,et al.  Pretreatment Hemostatic Markers of Symptomatic Intracerebral Hemorrhage in Patients Treated With Tissue Plasminogen Activator , 2006, Stroke.

[18]  M. Reichhart,et al.  Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis , 2005, Neurology.

[19]  J. Röther,et al.  Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (≥80 Years) Stroke Patients , 2005, Stroke.

[20]  V. Hachinski,et al.  Predictors of major neurologic improvement after thrombolysis in acute stroke , 2005, Neurology.

[21]  D. Emery,et al.  Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  G. Schlaug,et al.  Arterial Occlusive Lesions Recanalize More Frequently in Women Than in Men After Intravenous Tissue Plasminogen Activator Administration for Acute Stroke , 2005, Stroke.

[23]  P. Sandercock,et al.  Influence of Gender on Baseline Features and Clinical Outcomes among 17,370 Patients with Confirmed Ischaemic Stroke in the International Stroke Trial , 2005, Neuroepidemiology.

[24]  F. Silver,et al.  Sex Differences in Stroke Care and Outcomes: Results From the Registry of the Canadian Stroke Network , 2005, Stroke.

[25]  S. Warach,et al.  Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. , 2005, AJNR. American journal of neuroradiology.

[26]  L. Price,et al.  Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Pooled Analysis of Randomized Clinical Trials , 2005, Stroke.

[27]  P. Heuschmann,et al.  Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. , 2004, JAMA.

[28]  V. Hachinski,et al.  Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. , 2004, JAMA.

[29]  B. Norrving,et al.  Sex Differences in Management and Outcome After Stroke: A Swedish National Perspective , 2003, Stroke.

[30]  A. Carter,et al.  Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke , 2003, Journal of thrombosis and haemostasis : JTH.

[31]  Andrew M. Demchuk,et al.  Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey , 2002, Circulation.

[32]  D. Tanné,et al.  Predictors of good outcome after intravenous tPA for acute ischemic stroke , 2001, Neurology.

[33]  A. Carter,et al.  Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular disease , 2001, British journal of haematology.

[34]  A. Shah,et al.  Baseline Computed Tomography Changes and Clinical Outcome After Thrombolysis With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[35]  B. Crain,et al.  Estrogen Receptor Antagonist ICI182,780 Exacerbates Ischemic Injury in Female Mouse , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  Robert D. Brown,et al.  vator for acute ischemic stroke : feasibility , safety , and efficacy in the first year of clinical practice , 1999 .

[37]  Wei Li,et al.  Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. , 1998, Stroke.

[38]  J. Grotta,et al.  Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. , 1998, Stroke.

[39]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .